PET scan for fibrotic lung disease with memory problems
Part of Lungs & breathing, Mental health clinical trials.
This study tests a new imaging method that may help doctors see whether certain types of lung scarring are linked to memory and thinking issues. If you have a chronic lung condition and also notice memory problems, this scan could give more information about your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of lung disease that causes scarring (called interstitial lung disease), such as from an autoimmune condition or exposure to dusts or molds.
- You have had a chest CT scan in the last 6 months that confirmed your lung disease.
- Your lung function tests show moderate impairment (specific values between 30-80% for gas exchange and 40-70% for forced vital capacity).
- You have had memory loss or other thinking problems for at least 3 months, and you have been diagnosed with mild cognitive impairment, Alzheimer's disease, or another dementia-related condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
This study tests whether a new PET/CT scan using a radioactive tracer called FAPI-46 can better see lung changes in people with interstitial lung disease. It might help doctors understand the disease activity better.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.